Effectiveness analysis and value incommensurability.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00624-w
- By:
- Publication type:
- Article
Works matching IS 14787547 AND DT 2025 AND VI 23 AND IP 1
Results: 19
1
2
Impact of China's diagnosis-intervention packet payment reform on pediatric pneumonia hospitalization costs: an interrupted time series analysis.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00623-x
- By:
- Publication type:
- Article
3
Out-of-pocket pharmaceutical expenditure and potential misuse of public resources - analysis in the Italian context.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00619-7
- By:
- Publication type:
- Article
4
Cost-utility analysis of olaparib assisted targeted therapy for BRCA mutation HER2-negative early breast cancer in China and in the United States.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00617-9
- By:
- Publication type:
- Article
5
Cost-effectiveness analysis of nephroprotection programs for patients with type 2 diabetes mellitus in insurers in Colombia.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00618-8
- By:
- Publication type:
- Article
6
Health economic evaluation of trans-tibial prosthetic suspension systems: a protocol for a pilot using an observational study and synthetic cohort.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00611-1
- By:
- Publication type:
- Article
7
A systematic review of the current application status of decision-analytical models in the pharmacoeconomic evaluation of targeted therapies for pulmonary arterial hypertension.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00621-z
- By:
- Publication type:
- Article
8
Willingness to join community-based health insurance and associated factors among households in Ethiopian: a systematic review and meta-analysis.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00620-0
- By:
- Publication type:
- Article
9
Association between medical insurance and life satisfaction among middle-aged and older adults in China: the mediating role of depression.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-024-00584-7
- By:
- Publication type:
- Article
10
Operationalizing game-theoretic weighting in public hospital cost control: an implementation framework from Chinese tertiary hospitals.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00616-w
- By:
- Publication type:
- Article
11
A cost-utility analysis of long-acting insulin analogues (detemir, glargine and degludec) for the treatment of adult type 1 diabetes in South Africa.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00615-x
- By:
- Publication type:
- Article
12
Cost-effectiveness of sacituzumab govitecan for hormone receptor-positive human epidermal growth factor receptor 2-negative metastatic breast cancer based on the EVER-132-002 trial in China.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00613-z
- By:
- Publication type:
- Article
13
Factors influencing the demand for individual voluntary private health insurance in Iran.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00609-9
- By:
- Publication type:
- Article
14
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-024-00600-w
- By:
- Publication type:
- Article
15
Cost-effectiveness of nirmatrelvir/ritonavir in COVID-19 patient groups at high risk for progression to severe COVID-19 in the Netherlands.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00604-0
- By:
- Publication type:
- Article
16
Comparative Efficiency Analysis of OECD Health Systems: FDH vs. Machine Learning Approaches with Efficiency Analysis Trees (EAT and RFEAT).
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00607-x
- By:
- Publication type:
- Article
17
The cost-effectiveness analysis of newborn screening for inherited metabolic disorders in China using tandem mass spectrometry: a real-world evidence.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00608-w
- By:
- Publication type:
- Article
18
The effect of Covid-19 pandemic on the primary health care utilization and cost: an interrupted time series analysis.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00606-y
- By:
- Publication type:
- Article
19
Cost-effectiveness and budget impact of covering Burkitt lymphoma in children under Ghana's National Health Insurance Scheme.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-025-00603-1
- By:
- Publication type:
- Article